StabiLux Biosciences

Ann Arbor, MI · Founded 2014 · Privately Held (backing)

Developer of high-brightness fluorophores designed to improve the reagents that run through flow cytometers. StabiLux Biosciences is based in Ann Arbor, MI and was founded in 2014. It has raised $1.9 million across 1 recorded round; the latest was a $554,381 seed round in Apr 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$1.9M
Last round
Seed Round
Apr 2024
How much has StabiLux Biosciences raised?
$1.9Macross 1 recorded rounds · Apr 2024 – Apr 2024

Most recently, StabiLux Biosciences raised $554K in its Seed Round (Apr 2024).

Free account
More of StabiLux Biosciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch StabiLux Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

StabiLux Biosciences round by round

1 rounds
Apr 2024Seed Round$554KSEC filing▮
9 investors participated

How much has StabiLux Biosciences raised?

StabiLux Biosciences has raised $1.9 million in total; 1 of its rounds is on record. The largest on record was a $554,381 seed round in Apr 2024.

StabiLux Biosciences has filed 1 Form D with the SEC, most recently in May 2024 ($554,381 sold to 9 investors).

StabiLux Biosciences investors

12 investors are on record for StabiLux Biosciences, including US National Science Foundation, Invest Detroit Ventures, Lateral Capital Management and Michigan Economic Development. The seed round in Apr 2024 drew 9 investors.

For fundraisers
Raising for a company like StabiLux Biosciences?

12 investors have backed StabiLux Biosciences.

See all 12 investors →

Frequently asked about StabiLux Biosciences

How much has StabiLux Biosciences raised?
StabiLux Biosciences has raised $1.9M in total across 1 recorded funding rounds.
When was StabiLux Biosciences's last funding round?
StabiLux Biosciences's most recent recorded round was Seed Round in Apr 2024, raising $554K.